“CLINICAL OBSERVATION OF THE USE OF ORAL VINORELBINE IN THE TREATMENT OF DISSEMINATED ESTROGEN-RECEPTORPOSITIVE, HER2-NEGATIVE BREAST CANCER”. 2022. World Bulletin of Social Sciences 7 (February): 1-4. https://scholarexpress.net/index.php/wbss/article/view/514.